{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T02:20:37Z","timestamp":1768530037368,"version":"3.49.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003329","name":"MINECO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.bcp.2019.02.029","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T11:42:07Z","timestamp":1551267727000},"page":"321-334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Cannabinoid derivatives acting as dual PPAR\u03b3\/CB2 agonists as therapeutic agents for systemic sclerosis"],"prefix":"10.1016","volume":"163","author":[{"given":"Adela","family":"Garc\u00eda-Mart\u00edn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mart\u00edn","family":"Garrido-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Navarrete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Caprioglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bel\u00e9n","family":"Palomares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim","family":"DeMesa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Rollland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Appendino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8478-5842","authenticated-orcid":false,"given":"Eduardo","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2019.02.029_b0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/ITT.S82037","article-title":"Current perspectives on the immunopathogenesis of systemic sclerosis","volume":"5","author":"Fuschiotti","year":"2016","journal-title":"Immunotargets Ther."},{"key":"10.1016\/j.bcp.2019.02.029_b0010","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fimmu.2015.00272","article-title":"Pathogenesis of Systemic Sclerosis","volume":"6","author":"Pattanaik","year":"2015","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.bcp.2019.02.029_b0015","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0002-9343(69)90044-8","article-title":"Pathologic observations in systemic sclerosis (scleroderma) A study of fifty-eight autopsy cases and fifty-eight matched controls","volume":"46","author":"D'Angelo","year":"1969","journal-title":"Am. J. Med."},{"issue":"4","key":"10.1016\/j.bcp.2019.02.029_b0020","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0046-8177(97)90032-0","article-title":"Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection","volume":"28","author":"Cool","year":"1997","journal-title":"Hum. Pathol."},{"issue":"11","key":"10.1016\/j.bcp.2019.02.029_b0025","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1346-8138.2007.00381.x","article-title":"Autopsy case of systemic sclerosis with severe pulmonary hypertension","volume":"34","author":"Nagai","year":"2007","journal-title":"J. Dermatol."},{"issue":"5","key":"10.1016\/j.bcp.2019.02.029_b0030","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/sarh.2002.50011","article-title":"Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis","volume":"32","author":"Cerinic","year":"2003","journal-title":"Semin. Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.bcp.2019.02.029_b0035","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5152\/eurjrheum.2017.17025","article-title":"The endocannabinoid system in pain and inflammation: its relevance to rheumatic disease","volume":"4","author":"Barrie","year":"2017","journal-title":"Eur. J. Rheumatol."},{"key":"10.1016\/j.bcp.2019.02.029_b0040","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/bs.apha.2017.03.008","article-title":"The role of nuclear hormone receptors in cannabinoid function","volume":"80","author":"Pistis","year":"2017","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.bcp.2019.02.029_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2018.08.022","article-title":"The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders","author":"Rio","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2019.02.029_b0050","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1136\/annrheumdis-2012-201823","article-title":"Inactivation of fatty acid amide hydrolase exacerbates experimental fibrosis by enhanced endocannabinoid-mediated activation of CB1","volume":"71","author":"Palumbo-Zerr","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.bcp.2019.02.029_b0055","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1002\/art.27642","article-title":"Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis","volume":"62","author":"Marquart","year":"2010","journal-title":"Arthritis Rheumatism"},{"issue":"1","key":"10.1016\/j.bcp.2019.02.029_b0060","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2353\/ajpath.2010.090763","article-title":"Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis","volume":"177","author":"Servettaz","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.bcp.2019.02.029_b0065","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/art.24395","article-title":"The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis","volume":"60","author":"Akhmetshina","year":"2009","journal-title":"Arthritis Rheumatism"},{"issue":"3","key":"10.1016\/j.bcp.2019.02.029_b0070","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/FJC.0b013e3181d2644d","article-title":"Activation of cannabinoid CB2 receptor ameliorates atherosclerosis associated with suppression of adhesion molecules","volume":"55","author":"Zhao","year":"2010","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2019.02.029_b0075","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/BOR.0b013e32833de1a7","article-title":"Peroxisome proliferator-activated receptor gamma: innate protection from excessive fibrogenesis and potential therapeutic target in systemic sclerosis","volume":"22","author":"Wei","year":"2010","journal-title":"Curr. Opin. Rheumatol."},{"issue":"2","key":"10.1016\/j.bcp.2019.02.029_b0080","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2353\/ajpath.2009.080574","article-title":"Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma","volume":"174","author":"Wu","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"9","key":"10.1016\/j.bcp.2019.02.029_b0085","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/annrheumdis-2011-200314","article-title":"Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis","volume":"71","author":"Gonzalez","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.bcp.2019.02.029_b0090","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1096\/fj.08-128736","article-title":"Peroxisome proliferator-activated receptor-gamma abrogates Smad-dependent collagen stimulation by targeting the p300 transcriptional coactivator","volume":"23","author":"Ghosh","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2019.02.029_b0095","first-page":"124624","article-title":"The role of PPAR gamma in systemic sclerosis","author":"Dantas","year":"2015","journal-title":"PPAR Res."},{"key":"10.1016\/j.bcp.2019.02.029_b0100","doi-asserted-by":"crossref","first-page":"21703","DOI":"10.1038\/srep21703","article-title":"The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-\u03b3 and CB2 pathways","volume":"6","author":"del R\u00edo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2019.02.029_b0105","article-title":"Potent anti-inflammatory and pro-resolving effects of anabasum in a human model of self-resolving acute inflammation","author":"Motwani","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2019.02.029_b0110","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12974-018-1103-y","article-title":"Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy","volume":"15","author":"Navarrete","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.bcp.2019.02.029_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2018.07.047","article-title":"EHP-101, an oral formulation of the cannabidiol aminoquinone VCE-004.8, alleviates bleomycin-induced skin and lung fibrosis","author":"Garcia-Martin","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"13","key":"10.1016\/j.bcp.2019.02.029_b0120","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1016\/j.bmc.2014.04.062","article-title":"Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activity","volume":"22","author":"Tepper","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2019.02.029_b0125","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/jcp.41.4.467","article-title":"Simple method of estimating severity of pulmonary fibrosis on a numerical scale","volume":"41","author":"Ashcroft","year":"1988","journal-title":"J. Clin. Pathol."},{"issue":"15","key":"10.1016\/j.bcp.2019.02.029_b0130","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.bcp.2019.02.029_b0135","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat. Methods"},{"issue":"7","key":"10.1016\/j.bcp.2019.02.029_b0140","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"Feature counts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"issue":"12","key":"10.1016\/j.bcp.2019.02.029_b0145","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"issue":"5","key":"10.1016\/j.bcp.2019.02.029_b0150","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"issue":"43","key":"10.1016\/j.bcp.2019.02.029_b0155","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"10.1016\/j.bcp.2019.02.029_b0160","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"issue":"1","key":"10.1016\/j.bcp.2019.02.029_b0165","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12931-016-0373-0","article-title":"Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung","volume":"17","author":"Lucattelli","year":"2016","journal-title":"Respir. Res."},{"issue":"7","key":"10.1016\/j.bcp.2019.02.029_b0170","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nrrheum.2016.99","article-title":"Systemic sclerosis: tenascin C perpetuates tissue fibrosis","volume":"12","author":"Ummarino","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"issue":"4","key":"10.1016\/j.bcp.2019.02.029_b0175","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1523-1747.1999.00528.x","article-title":"Animal model of sclerotic skin. I: local injections of bleomycin induce sclerotic skin mimicking scleroderma","volume":"112","author":"Yamamoto","year":"1999","journal-title":"J. Investig. Dermatol."},{"issue":"12","key":"10.1016\/j.bcp.2019.02.029_b0180","first-page":"2628","article-title":"Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W\/W(V) mice","volume":"26","author":"Yamamoto","year":"1999","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bcp.2019.02.029_b0185","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/270938","article-title":"Vascular changes in bleomycin-induced scleroderma","volume":"2011","author":"Yamamoto","year":"2011","journal-title":"Int. J. Rheumatol."},{"issue":"7","key":"10.1016\/j.bcp.2019.02.029_b0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002696","article-title":"Molecular subsets in the gene expression signatures of scleroderma skin","volume":"3","author":"Milano","year":"2008","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.bcp.2019.02.029_b0195","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J. Clin. Investig."},{"issue":"8","key":"10.1016\/j.bcp.2019.02.029_b0200","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/art.37988","article-title":"Review: evidence that systemic sclerosis is a vascular disease","volume":"65","author":"Matucci-Cerinic","year":"2013","journal-title":"Arthritis Rheumatism"},{"issue":"4","key":"10.1016\/j.bcp.2019.02.029_b0205","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/jcmm.12028","article-title":"Evidence for progressive reduction and loss of telocytes in the dermal cellular network of systemic sclerosis","volume":"17","author":"Manetti","year":"2013","journal-title":"J. Cell Mol. Med."},{"issue":"2","key":"10.1016\/j.bcp.2019.02.029_b0210","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1182\/blood-2018-01-769018","article-title":"von Willebrand factor regulation of blood vessel formation","volume":"132","author":"Randi","year":"2018","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bcp.2019.02.029_b0215","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/jcmm.12228","article-title":"A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis","volume":"18","author":"Manetti","year":"2014","journal-title":"J. Cell Mol. Med."},{"issue":"5","key":"10.1016\/j.bcp.2019.02.029_b0220","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1101\/gad.1881410","article-title":"Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis","volume":"24","author":"Takeda","year":"2010","journal-title":"Genes Dev."},{"issue":"5","key":"10.1016\/j.bcp.2019.02.029_b0225","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1517\/14656561003592177","article-title":"Pharmacotherapy of systemic sclerosis","volume":"11","author":"Postlethwaite","year":"2010","journal-title":"Expert Opin. Pharmacother."},{"issue":"3","key":"10.1016\/j.bcp.2019.02.029_b0230","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00109-011-0824-5","article-title":"Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system","volume":"90","author":"Lazzerini","year":"2012","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"6","key":"10.1016\/j.bcp.2019.02.029_b0235","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.autrev.2016.02.008","article-title":"Cannabinoids and autoimmune diseases: a systematic review","volume":"15","author":"Katchan","year":"2016","journal-title":"Autoimmun. Rev."},{"issue":"11","key":"10.1016\/j.bcp.2019.02.029_b0240","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1096\/fj.201600646R","article-title":"Cannabinoids, inflammation, and fibrosis","volume":"30","author":"Zurier","year":"2016","journal-title":"FASEB J"},{"issue":"19","key":"10.1016\/j.bcp.2019.02.029_b0245","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1111\/bph.14450","article-title":"VCE-004.3, a cannabidiol aminoquinone derivative, prevents bleomycin-induced skin fibrosis and inflammation through PPARgamma- and CB2 receptor-dependent pathways","volume":"175","author":"Del Rio","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.bcp.2019.02.029_b0250","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/art.39658","article-title":"Identification of optimal mouse models of systemic sclerosis by interspecies comparative genomics","volume":"68","author":"Sargent","year":"2016","journal-title":"Arthritis Rheumatol."},{"issue":"5","key":"10.1016\/j.bcp.2019.02.029_b0255","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/jid.2011.472","article-title":"Intrinsic gene expression subsets of diffuse cutaneous systemic sclerosis are stable in serial skin biopsies","volume":"132","author":"Pendergrass","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bcp.2019.02.029_b0260","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.steroids.2017.08.012","article-title":"Corticosteroid inhibits chemokines production in systemic sclerosis patients","volume":"127","author":"Dantas","year":"2017","journal-title":"Steroids"},{"issue":"3","key":"10.1016\/j.bcp.2019.02.029_b0265","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/ar4230","article-title":"Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells","volume":"15","author":"Gilbane","year":"2013","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.bcp.2019.02.029_b0270","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1365-2249.2006.03199.x","article-title":"Hypoxia induces expression of connective tissue growth factor in scleroderma skin fibroblasts","volume":"146","author":"Hong","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bcp.2019.02.029_b0275","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3389\/fimmu.2013.00266","article-title":"The role of type 1 interferon in systemic sclerosis","volume":"4","author":"Wu","year":"2013","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2019.02.029_b0280","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11926-009-0015-3","article-title":"Is scleroderma a vasculopathy?","volume":"11","author":"Fleming","year":"2009","journal-title":"Curr. Rheumatol. Rep."},{"issue":"3","key":"10.1016\/j.bcp.2019.02.029_b0285","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/08916930903510963","article-title":"Interferon-alpha as angiogenesis inhibitor: learning from tumor models","volume":"43","author":"Indraccolo","year":"2010","journal-title":"Autoimmunity"},{"issue":"4","key":"10.1016\/j.bcp.2019.02.029_b0290","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.4049\/jimmunol.166.4.2276","article-title":"IFN-gamma-dependent inhibition of tumor angiogenesis by tumor-infiltrating CD4+ T cells requires tumor responsiveness to IFN-gamma","volume":"166","author":"Beatty","year":"2001","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.bcp.2019.02.029_b0295","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1136\/annrheumdis-2018-213239","article-title":"Slit2\/Robo4 axis may contribute to endothelial cell dysfunction and angiogenesis disturbance in systemic sclerosis","volume":"77","author":"Romano","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.bcp.2019.02.029_b0300","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.mehy.2013.09.001","article-title":"Scube regulates synovial angiogenesis-related signaling","volume":"81","author":"Yang","year":"2013","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.bcp.2019.02.029_b0305","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3389\/fphys.2018.01177","article-title":"The role of oxidative stress in the development of systemic sclerosis related vasculopathy","volume":"9","author":"Abdulle","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bcp.2019.02.029_b0310","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/835948","article-title":"Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis","volume":"2013","author":"Jimenez","year":"2013","journal-title":"ISRN Rheumatol."},{"issue":"4","key":"10.1016\/j.bcp.2019.02.029_b0315","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.immuni.2014.09.008","article-title":"HIF transcription factors, inflammation, and immunity","volume":"41","author":"Palazon","year":"2014","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.bcp.2019.02.029_b0320","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/(SICI)1096-9896(199910)189:2<273::AID-PATH413>3.0.CO;2-4","article-title":"Endothelial expression of nitric oxide synthases and nitrotyrosine in systemic sclerosis skin","volume":"189","author":"Cotton","year":"1999","journal-title":"J. Pathol."},{"issue":"3","key":"10.1016\/j.bcp.2019.02.029_b0325","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.bcp.2019.02.029_b0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000371","article-title":"Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis","volume":"5","author":"Pesce","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bcp.2019.02.029_b0335","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.addr.2015.06.001","article-title":"Vascularization strategies of engineered tissues and their application in cardiac regeneration","volume":"96","author":"Sun","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.bcp.2019.02.029_b0340","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/scd.2013.0268","article-title":"Hypoxia, leptin, and vascular endothelial growth factor stimulate vascular endothelial cell differentiation of human adipose tissue-derived stem cells","volume":"23","author":"Bekhite","year":"2014","journal-title":"Stem Cells Dev."},{"issue":"5","key":"10.1016\/j.bcp.2019.02.029_b0345","first-page":"474","article-title":"CD34-positive stem cells: in the treatment of heart and vascular disease in human beings","volume":"38","author":"Mackie","year":"2011","journal-title":"Tex. Heart Inst. J."},{"issue":"3","key":"10.1016\/j.bcp.2019.02.029_b0350","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/ar295","article-title":"Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma)","volume":"3","author":"Scheja","year":"2001","journal-title":"Arthritis Res."},{"issue":"9434","key":"10.1016\/j.bcp.2019.02.029_b0355","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(04)16853-0","article-title":"Defective vasculogenesis in systemic sclerosis","volume":"364","author":"Kuwana","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2019.02.029_b0360","doi-asserted-by":"crossref","first-page":"8323747","DOI":"10.1155\/2016\/8323747","article-title":"Regulation of hepatic stellate cells and fibrogenesis by fibroblast growth factors","volume":"2016","author":"Schumacher","year":"2016","journal-title":"Biomed Res. Int."},{"issue":"8","key":"10.1016\/j.bcp.2019.02.029_b0365","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708791","article-title":"FGF21 gene therapy as treatment for obesity and insulin resistance","volume":"10","author":"Jimenez","year":"2018","journal-title":"EMBO Mol. Med."},{"issue":"8","key":"10.1016\/j.bcp.2019.02.029_b0370","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/ncb3555","article-title":"Dll4 and Notch signalling couples sprouting angiogenesis and artery formation","volume":"19","author":"Pitulescu","year":"2017","journal-title":"Nat. Cell Biol."},{"issue":"9","key":"10.1016\/j.bcp.2019.02.029_b0375","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.prp.2018.02.014","article-title":"MicroRNA-30d\/JAG1 axis modulates pulmonary fibrosis through Notch signaling pathway","volume":"214","author":"Zhao","year":"2018","journal-title":"Pathol. Res. Pract."},{"issue":"10","key":"10.1016\/j.bcp.2019.02.029_b0380","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1002\/art.22874","article-title":"Down-regulation of collagen and connective tissue growth factor expression with hepatocyte growth factor in lung fibroblasts from white scleroderma patients via two signaling pathways","volume":"56","author":"Bogatkevich","year":"2007","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.bcp.2019.02.029_b0385","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.coph.2018.02.011","article-title":"Angiogenesis in peripheral arterial disease","volume":"39","author":"Inampudi","year":"2018","journal-title":"Curr. Opin. Pharmacol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219300772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219300772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:08:01Z","timestamp":1757768881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295219300772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":77,"alternative-id":["S0006295219300772"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2019.02.029","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabinoid derivatives acting as dual PPAR\u03b3\/CB2 agonists as therapeutic agents for systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2019.02.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}